phenylpiperazine has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Huang, J; Huang, X; Song, S; Sun, X; Wang, Z; Xiao, Q; Zhao, S | 1 |
| Deng, Y; Fu, S; He, F; Huang, JJ; Huang, X; Liu, XW; Sun, X; Yang, L; Zhao, S | 1 |
2 other study(ies) available for phenylpiperazine and Candidiasis
| Article | Year |
|---|---|
Anti-virulence activity of novel (1-heteroaryloxy-2-hydroxypropyl)- phenylpiperazine derivatives against both wild-type and clinical drug-resistant Candida albicans strains.
Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Humans; Mice; Piperazines | 2023 |
(1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Humans; Hyphae; Piperazines; Virulence | 2018 |